Laboratory characteristics of suspected herpes zoster in vaccinated children

Pediatric Infectious Disease Journal

Volumn 30, Issue 8, 2011, Pages 721-723

  Chun, Colleen ^a   Weinmann, Sheila ^b   Riedlinger, Karen ^b   Mullooly, John P ^b   Houston, Heather ^b   Schmid, D Scott ^c   Seward, Jane F ^d  

^a Northwest Permanente   (United States)

^b CENTER FOR HEALTH RESEARCH   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

herpes zoster; varicella vaccine

Indexed keywords

CHICKENPOX VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ARTICLE; CHICKENPOX; CHILD; CLINICAL ARTICLE; FEMALE; HERPES ZOSTER; HUMAN; INFANT; LABORATORY TEST; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION; VARICELLA ZOSTER VIRUS;

EID: 79960633383     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182137e35     Document Type: Article

References (12)

1. Chaves SS, Haber P, Walton K, et al. Safety of varicella vaccine after licensure in the United States: Experience from reports to the vaccine adverse event reporting system, 1995-2005. J Infect Dis. 2008;197:S170-S177. (Pubitemid 351590167)
2. Weinmann S, Chun C, Mullooly J, et al. Laboratory diagnosis and characteristics of breakthrough varicella in children. J Infect Dis. 2008;197:S132-S138. (Pubitemid 351590160)
3. Loparev VN, McCaustland K, Holloway BP, et al. Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes. J Clin Microbiol. 2000;38:4315-4319. (Pubitemid 32244512)
4. Takayama N, Yamada H, Kaku H, et al. Herpes zoster in immunocompetent and immunocompromised Japanese children. Pediatr Int. 2000;42:275-279. (Pubitemid 30409342)
5. Guris D, Jumaan AO, Mascola L, et al. Changing varicella epidemiology in active surveillance sites-United States, 1995-2005. J Infect Dis. 2008; 197:S71-S75. (Pubitemid 351590150)
6. Uebe B, Sauerbrei A, Burdach S, et al. Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child. Eur J Pediatr. 2002;161:442-444. (Pubitemid 34969523)
7. Sauerbrei A. Eichhorn U, Schacke M, et al. Laboratory diagnosis of herpes zoster. J Clin Virol. 1999;14:31-36. (Pubitemid 29454635)
8. Dobec M, Bossart W, Kaeppeli F, et al. Serology and serum DNA detection in shingles. Swiss Med Wkly. 2008;138:47-51. (Pubitemid 351184995)
9. Schmidt NJ, Arvin AM. Sensitivity of different assay systems for immunoglobulin M responses to varicella-zoster virus in reactivated infections (zoster). J Clin Microbiol. 1986;23:978-979. (Pubitemid 16120636)
10. Watson B, Gupta R, Randall T, et al. Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine. J Infect Dis. 1994;169:197-199.
11. Brisson M, Gay N, Edmunds W, et al. Exposure to varicella boosts immunity to herpes zoster: implications for mass vaccination against chickenpox. Vaccine. 2002;20:2500-2507. (Pubitemid 34615588)
12. Civen R, Chaves SS, Jumaan A, et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J. 2009;11:954-959.